-
2
-
-
0033932183
-
Who should follow up lung cancer patients after operation?
-
10892909 10.1016/S0003-4975(00)01145-0 1:STN:280:DC%2BD3czkvV2qug%3D%3D
-
S Gilbert KR Reid MY Lam D Petsikas 2000 Who should follow up lung cancer patients after operation? Ann Thorac Surg. 69 1696 1700 10892909 10.1016/S0003-4975(00)01145-0 1:STN:280:DC%2BD3czkvV2qug%3D%3D
-
(2000)
Ann Thorac Surg.
, vol.69
, pp. 1696-1700
-
-
Gilbert, S.1
Reid, K.R.2
Lam, M.Y.3
Petsikas, D.4
-
3
-
-
33646230046
-
Cohypermethylation of p16 and FHIT promoters as a prognostic factor of recurrence in surgically resected stage i non-small cell lung cancer
-
16618724 10.1158/0008-5472.CAN-05-3813 1:CAS:528:DC%2BD28XjsFSltr4%3D
-
JS Kim JW Kim J Han YM Shim J Park DH Kim 2006 Cohypermethylation of p16 and FHIT promoters as a prognostic factor of recurrence in surgically resected stage I non-small cell lung cancer Cancer Res. 66 4049 4054 16618724 10.1158/0008-5472.CAN-05-3813 1:CAS:528:DC%2BD28XjsFSltr4%3D
-
(2006)
Cancer Res.
, vol.66
, pp. 4049-4054
-
-
Kim, J.S.1
Kim, J.W.2
Han, J.3
Shim, Y.M.4
Park, J.5
Kim, D.H.6
-
4
-
-
0346238665
-
Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer
-
14736927 10.1056/NEJMoa031644
-
R Arriagada B Bergman A Dunant T Le Chevalier JP Pignon J Vansteenkiste 2004 Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer N Engl J Med. 350 351 360 14736927 10.1056/NEJMoa031644
-
(2004)
N Engl J Med.
, vol.350
, pp. 351-360
-
-
Arriagada, R.1
Bergman, B.2
Dunant, A.3
Le Chevalier, T.4
Pignon, J.P.5
Vansteenkiste, J.6
-
5
-
-
55549138045
-
Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the cancer and leukemia group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups
-
18809614 10.1200/JCO.2008.16.4855 1:CAS:528:DC%2BD1cXhsVGhsrvM
-
GM Strauss JE Herndon 2nd MA Maddaus, et al. 2008 Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the cancer and leukemia group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups J Clin Oncol. 26 5043 5051 18809614 10.1200/JCO.2008.16.4855 1:CAS:528: DC%2BD1cXhsVGhsrvM
-
(2008)
J Clin Oncol.
, vol.26
, pp. 5043-5051
-
-
Strauss, G.M.1
Herndon II, J.E.2
Maddaus, M.A.3
-
6
-
-
34248143870
-
National Cancer Institute of Canada and Intergroup Study JBR.10. Adjuvant vinorelbine and cisplatin in elderly patients: National Cancer Institute of Canada and Intergroup Study JBR.10
-
17442999 10.1200/JCO.2006.09.5570 1:CAS:528:DC%2BD2sXlsVynurw%3D
-
C Pepe B Hasan TL Winton, et al. 2007 National Cancer Institute of Canada and Intergroup Study JBR.10. Adjuvant vinorelbine and cisplatin in elderly patients: National Cancer Institute of Canada and Intergroup Study JBR.10 J Clin Oncol. 25 1553 1561 17442999 10.1200/JCO.2006.09.5570 1:CAS:528: DC%2BD2sXlsVynurw%3D
-
(2007)
J Clin Oncol.
, vol.25
, pp. 1553-1561
-
-
Pepe, C.1
Hasan, B.2
Winton, T.L.3
-
7
-
-
0034668152
-
Cyclin A2 transcriptional regulation: Modulation of cell cycle control at the G1/S transition by peripheral cues
-
11007956 10.1016/S0006-2952(00)00384-1 1:CAS:528:DC%2BD3cXmslOjtrw%3D
-
JM Blanchard 2000 Cyclin A2 transcriptional regulation: modulation of cell cycle control at the G1/S transition by peripheral cues Biochem Pharmacol. 60 1179 1184 11007956 10.1016/S0006-2952(00)00384-1 1:CAS:528: DC%2BD3cXmslOjtrw%3D
-
(2000)
Biochem Pharmacol.
, vol.60
, pp. 1179-1184
-
-
Blanchard, J.M.1
-
8
-
-
8244226661
-
Cyclin A is associated with an unfavourable outcome in patients with non-small-cell lung carcinoma
-
9192980 10.1038/bjc.1997.302 1:CAS:528:DyaK2sXksVWqsLg%3D
-
M Volm R Koomagi J Mattern G Stammler 1997 Cyclin A is associated with an unfavourable outcome in patients with non-small-cell lung carcinoma Br J Cancer. 75 1774 1778 9192980 10.1038/bjc.1997.302 1:CAS:528:DyaK2sXksVWqsLg%3D
-
(1997)
Br J Cancer.
, vol.75
, pp. 1774-1778
-
-
Volm, M.1
Koomagi, R.2
Mattern, J.3
Stammler, G.4
-
9
-
-
0037316746
-
Diversity in expression and prognostic significance of G1/S cyclins in human primary lung carcinomas
-
12533834 10.1002/path.1247 1:CAS:528:DC%2BD3sXhs1ynsr0%3D
-
Y Dobashi M Shoji SX Jiang M Kobayashi Y Kawakubo T Kameya 2003 Diversity in expression and prognostic significance of G1/S cyclins in human primary lung carcinomas J Pathol. 199 208 220 12533834 10.1002/path.1247 1:CAS:528:DC%2BD3sXhs1ynsr0%3D
-
(2003)
J Pathol.
, vol.199
, pp. 208-220
-
-
Dobashi, Y.1
Shoji, M.2
Jiang, S.X.3
Kobayashi, M.4
Kawakubo, Y.5
Kameya, T.6
-
10
-
-
0035863322
-
Cyclin e is the only cyclin-dependent kinase 2-associated cyclin that predicts metastasis and survival in early stage non-small cell lung cancer
-
11212263
-
C Müller-Tidow R Metzger K Kügler, et al. 2001 Cyclin E is the only cyclin-dependent kinase 2-associated cyclin that predicts metastasis and survival in early stage non-small cell lung cancer Cancer Res. 61 647 653 11212263
-
(2001)
Cancer Res.
, vol.61
, pp. 647-653
-
-
Müller-Tidow, C.1
Metzger, R.2
Kügler, K.3
-
11
-
-
68049120610
-
Expression and prognostic significance of cyclin B1 and cyclin A in non-small cell lung cancer
-
19614764 10.1111/j.1365-2559.2009.03331.x
-
WA Cooper MR Kohonen-Corish B McCaughan C Kennedy RL Sutherland CS Lee 2009 Expression and prognostic significance of cyclin B1 and cyclin A in non-small cell lung cancer Histopathology. 55 28 36 19614764 10.1111/j.1365-2559.2009.03331.x
-
(2009)
Histopathology.
, vol.55
, pp. 28-36
-
-
Cooper, W.A.1
Kohonen-Corish, M.R.2
McCaughan, B.3
Kennedy, C.4
Sutherland, R.L.5
Lee, C.S.6
-
12
-
-
0028234519
-
Participation of cyclin A in Myc-induced apoptosis
-
8041712 10.1073/pnas.91.15.6875 1:CAS:528:DyaK2cXltVGhtrY%3D
-
AT Hoang KJ Cohen JF Barrett DA Bergstrom CV Dang 1994 Participation of cyclin A in Myc-induced apoptosis Proc Natl Acad Sci USA. 91 6875 6879 8041712 10.1073/pnas.91.15.6875 1:CAS:528:DyaK2cXltVGhtrY%3D
-
(1994)
Proc Natl Acad Sci USA.
, vol.91
, pp. 6875-6879
-
-
Hoang, A.T.1
Cohen, K.J.2
Barrett, J.F.3
Bergstrom, D.A.4
Dang, C.V.5
-
13
-
-
0028230814
-
Activation of cyclin A-dependent protein kinases during apoptosis
-
8170983 10.1073/pnas.91.9.3754 1:CAS:528:DyaK2cXivFGiurc%3D
-
W Meikrantz S Gisselbrecht SW Tam R Schlegel 1994 Activation of cyclin A-dependent protein kinases during apoptosis Proc Natl Acad Sci USA. 91 3754 3758 8170983 10.1073/pnas.91.9.3754 1:CAS:528:DyaK2cXivFGiurc%3D
-
(1994)
Proc Natl Acad Sci USA.
, vol.91
, pp. 3754-3758
-
-
Meikrantz, W.1
Gisselbrecht, S.2
Tam, S.W.3
Schlegel, R.4
-
14
-
-
0029880622
-
Suppression of apoptosis by dominant negative mutants of cyclin-dependent protein kinases
-
8626584 10.1074/jbc.271.17.10205 1:CAS:528:DyaK28XisFKjs74%3D
-
W Meikrantz R Schlegel 1996 Suppression of apoptosis by dominant negative mutants of cyclin-dependent protein kinases J Biol Chem. 271 10205 10209 8626584 10.1074/jbc.271.17.10205 1:CAS:528:DyaK28XisFKjs74%3D
-
(1996)
J Biol Chem.
, vol.271
, pp. 10205-10209
-
-
Meikrantz, W.1
Schlegel, R.2
-
16
-
-
78549283515
-
Cystatin M loss is associated with the losses of estrogen receptor, progesterone receptor, and HER4 in invasive breast cancer
-
21092257 10.1186/bcr2783 1:CAS:528:DC%2BC3cXhsFagt7rN
-
E Ko SE Park EY Cho, et al. 2010 Cystatin M loss is associated with the losses of estrogen receptor, progesterone receptor, and HER4 in invasive breast cancer Breast Cancer Res. 12 R100 21092257 10.1186/bcr2783 1:CAS:528: DC%2BC3cXhsFagt7rN
-
(2010)
Breast Cancer Res.
, vol.12
, pp. 100
-
-
Ko, E.1
Park, S.E.2
Cho, E.Y.3
-
17
-
-
0030916669
-
The proto-oncogene Bcl-2 and its role in regulating apoptosis
-
9176486 10.1038/nm0697-614 1:CAS:528:DyaK2sXjsFOisbs%3D
-
G Kroemer 1997 The proto-oncogene Bcl-2 and its role in regulating apoptosis Nat Med. 3 614 620 9176486 10.1038/nm0697-614 1:CAS:528: DyaK2sXjsFOisbs%3D
-
(1997)
Nat Med.
, vol.3
, pp. 614-620
-
-
Kroemer, G.1
-
18
-
-
0034120314
-
Bcl-2 overexpression and hypoxia synergistically act to modulate vascular endothelial growth factor expression and in vivo angiogenesis in a breast carcinoma line
-
10744622 1:CAS:528:DC%2BD3cXisFyhsrY%3D
-
A Biroccio A Candiloro M Mottolese, et al. 2000 Bcl-2 overexpression and hypoxia synergistically act to modulate vascular endothelial growth factor expression and in vivo angiogenesis in a breast carcinoma line FASEB J. 14 652 660 10744622 1:CAS:528:DC%2BD3cXisFyhsrY%3D
-
(2000)
FASEB J.
, vol.14
, pp. 652-660
-
-
Biroccio, A.1
Candiloro, A.2
Mottolese, M.3
-
19
-
-
20444456293
-
Bcl-2 acts in a proangiogenic signaling pathway through nuclear factor-kappaB and CXC chemokines
-
15958549 10.1158/0008-5472.CAN-05-0140 1:CAS:528:DC%2BD2MXltFemtbw%3D
-
E Karl K Warner B Zeitlin, et al. 2005 Bcl-2 acts in a proangiogenic signaling pathway through nuclear factor-kappaB and CXC chemokines Cancer Res. 65 5063 5069 15958549 10.1158/0008-5472.CAN-05-0140 1:CAS:528: DC%2BD2MXltFemtbw%3D
-
(2005)
Cancer Res.
, vol.65
, pp. 5063-5069
-
-
Karl, E.1
Warner, K.2
Zeitlin, B.3
-
20
-
-
21344473197
-
Bcl-2 promotes invasion and lung metastasis by inducing matrix metalloproteinase-2
-
15994927 10.1158/0008-5472.CAN-04-4570 1:CAS:528:DC%2BD2MXlslOqsrc%3D
-
J Choi K Choi EN Benveniste, et al. 2005 Bcl-2 promotes invasion and lung metastasis by inducing matrix metalloproteinase-2 Cancer Res. 65 5554 5560 15994927 10.1158/0008-5472.CAN-04-4570 1:CAS:528:DC%2BD2MXlslOqsrc%3D
-
(2005)
Cancer Res.
, vol.65
, pp. 5554-5560
-
-
Choi, J.1
Choi, K.2
Benveniste, E.N.3
-
21
-
-
0031471135
-
Potential role of Bcl-2 as a suppressor of tumour angiogenesis in non-small cell lung cancer
-
9421349 10.1002/(SICI)1097-0215(19971219)74:6<565::AID-IJC1>3.0. CO;2-S 1:CAS:528:DyaK1cXis1Kqtg%3D%3D
-
MI Koukourakis A Giatromanolaki KJ O'Byrne, et al. 1997 Potential role of Bcl-2 as a suppressor of tumour angiogenesis in non-small cell lung cancer Int J Cancer. 74 565 570 9421349 10.1002/(SICI)1097-0215(19971219)74:6<565::AID- IJC1>3.0.CO;2-S 1:CAS:528:DyaK1cXis1Kqtg%3D%3D
-
(1997)
Int J Cancer.
, vol.74
, pp. 565-570
-
-
Koukourakis, M.I.1
Giatromanolaki, A.2
O'Byrne, K.J.3
-
22
-
-
0029035891
-
Bcl-2 protein: A prognostic factor inversely correlated to p53 in non-small-cell lung cancer
-
7734290 10.1038/bjc.1995.193 1:STN:280:DyaK2M3lt1SnsA%3D%3D
-
G Fontanini S Vignati D Bigini, et al. 1995 Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer Br J Cancer. 71 1003 1007 7734290 10.1038/bjc.1995.193 1:STN:280:DyaK2M3lt1SnsA%3D%3D
-
(1995)
Br J Cancer.
, vol.71
, pp. 1003-1007
-
-
Fontanini, G.1
Vignati, S.2
Bigini, D.3
-
23
-
-
0037868819
-
Cyclin D1 overexpression in bronchial epithelia of patients with lung cancer is associated with smoking and predicts survival
-
12775733 10.1200/JCO.2003.03.103 1:CAS:528:DC%2BD2cXpsVGqtL0%3D
-
D Ratschiller J Heighway M Gugger, et al. 2003 Cyclin D1 overexpression in bronchial epithelia of patients with lung cancer is associated with smoking and predicts survival J Clin Oncol. 21 2085 2093 12775733 10.1200/JCO.2003.03. 103 1:CAS:528:DC%2BD2cXpsVGqtL0%3D
-
(2003)
J Clin Oncol.
, vol.21
, pp. 2085-2093
-
-
Ratschiller, D.1
Heighway, J.2
Gugger, M.3
|